covid-19 coronavirus news Coronavirus

Johnson & Johnson expects to release late-stage coronavirus vaccine data in January

Reading now: 737
globalnews.ca

coronavirus vaccine are now fully enrolled, and expects to release initial data on the shot’s effectiveness by the end of January.The company said roughly 45,000 participants in several countries have now signed up to receive the pharmaceutical company’s vaccine, which is being developed along with its medical research and development subsidiary, Janssen.

Johnson & Johnson’s single-dose COVID-19 vaccine candidate begins phase 3 trial “Given the high incidence of COVID-19 among the general population in the countries where the trial is being conducted, this number of participants will be sufficient to generate the data needed to determine the efficacy and safety of the Company’s investigational COVID-19 vaccine candidate,” the company said.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA